Publicación: Diez respuestas puntuales sobre neumonía adquirida en la comunidad en adultos
| dc.contributor.author | Bustillo Pereira, José Gabriel | spa |
| dc.date.accessioned | 2018-02-16T00:00:00Z | |
| dc.date.accessioned | 2025-08-05T14:41:48Z | |
| dc.date.available | 2018-02-16T00:00:00Z | |
| dc.date.available | 2025-08-05T14:41:48Z | |
| dc.date.issued | 2018-02-16 | |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.doi | 10.26752/ccomunitaria.v23.n132.312 | |
| dc.identifier.eissn | 2539-0503 | |
| dc.identifier.issn | 0123-1588 | |
| dc.identifier.uri | https://repositorio.juanncorpas.edu.co/handle/001/687 | |
| dc.identifier.url | https://doi.org/10.26752/ccomunitaria.v23.n132.312 | |
| dc.language.iso | spa | spa |
| dc.publisher | Fundación Universitaria Juan N. Corpas | spa |
| dc.relation.bitstream | https://revistas.juanncorpas.edu.co/index.php/cartacomunitaria/article/download/312/284 | |
| dc.relation.citationedition | Núm. 132 , Año 2015 : Carta Comunitaria N° 132 | spa |
| dc.relation.citationendpage | 82 | |
| dc.relation.citationissue | 132 | spa |
| dc.relation.citationstartpage | 62 | |
| dc.relation.citationvolume | 23 | spa |
| dc.relation.ispartofjournal | Carta Comunitaria | spa |
| dc.relation.references | Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia: Guidelines from the Infectious Disease Society of America. Clin Infect Dis. 2000; 31:347–382. | spa |
| dc.relation.references | Niederman M S, Bass J B Jr, Campbell G D, Fein A M, Grossman R F, Mandell L A, et al. American Thoracic Society guidelines for the initial management of adults with communityacquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 148: 1418-26. | spa |
| dc.relation.references | Woodhead M. Community-acquired Pneumonia Guidelines. An international comparison. A view from Europe. Chest 1998; 113: S183S-S187. | spa |
| dc.relation.references | Calmaggi A, Clara L, González Arzac M, López Furst M J, Levy Hara G. Guías para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad en adultos. Infect Microbiol Clin 2000 | spa |
| dc.relation.references | Bantar, C, Bavestrello, L, Curcio, D, Jasovich A, Absi R, Bagnulo H, et al. Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American Working Group (ConsenSur). J Chemother 2002; 14 (Suppl 4): 1-22. | spa |
| dc.relation.references | Mandell L, Wunderink R, Anzueto A, Bartlett J G, Campbell G D, Dean N C, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 2007; 44: 27-72. | spa |
| dc.relation.references | Diehr P, Wood RW, Bushyhead J, et al. Prediction of pneumonia in outpatients with acute cough—a statistical approach. J Chronic Dis 1984; 37:215–25. | spa |
| dc.relation.references | Spiteri MA, Cook DG, Clarke SW. Reliability of eliciting physical signs in examination of the chest. Lancet 1988; 1:873–5. | spa |
| dc.relation.references | Heckerling PS, Tape TG, Wigton RS, et al. Clinical prediction rule for pulmonary infiltrates. Ann Intern Med. 1990; 113:664-670. | spa |
| dc.relation.references | Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997; 157:1453–9. | spa |
| dc.relation.references | Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997; 278:1440–5. | spa |
| dc.relation.references | Saldías F., Méndez J., Ramírez D, Díaz O. Valor predictivo de la historia clínica y el examen físico en el diagnóstico de la neumonía del adulto adquirida en la comunidad. Revisión de la literatura. Rev Med Chile 2007; 135: 517-528. | spa |
| dc.relation.references | Levy M, Dromer F, Brion N, Leturdu F, Carbon C. Community-acquired pneumonia: importance of initial noninvasive bacteriologic and radiographic investigations. Chest 1988; 93: 43-8. | spa |
| dc.relation.references | Liapikou A, Ferrer M, Polverino E, Balasso V, Esperatti M, Piñer R, et al. Severe Community-acquired pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission. Clin Infect Dis 2009; 48: 377-85. | spa |
| dc.relation.references | Valencia M, Badia J R, Cavalcanti M, Ferrer M, index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest 2007; 132: 515-22. | spa |
| dc.relation.references | Renaud B, Coma E, Labarere J, Hayon J, Roy P M, Boureaux H, et al. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study. Clin Infect Dis 2007; 44: 41-9. | spa |
| dc.relation.references | Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax 2007; 62:253–9. | spa |
| dc.relation.references | Myint PK, Kamath AV, Vowler SL, Maisey DN, Harrison BD. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006; 35: 286-91. | spa |
| dc.relation.references | Bantar C et al. Neumonía aguda adquirida en la comunidad en adultos: Actualización de los lineamientos para el tratamiento antimicrobiano inicial basado en la evidencia local del Grupo de Trabajo de Sudamérica (ConsenSur II) Rev Chil Infect 2010; 27 (Supl 1): 9-38. | spa |
| dc.relation.references | Van der Eerden MM, Vlaspolder F, de Graaff CS, et al. Comparison between pathogen directed antibiotic treatment and empirical broads pectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax 2005; 60:672–8. | spa |
| dc.relation.references | Menendez R, Torres A, Zalacain R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004; 59:960–5. | spa |
| dc.relation.references | Mundy LM, Leet TL, Darst K, Schnitzler MA, Dunagan WC. Early mobilization of patients hospitalized with community-acquired pneumonia. Chest. 2003; 124 (3):883-889. | spa |
| dc.relation.references | Eliakim-Raz Noa, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev. 2012 Sep 12;9. | spa |
| dc.relation.references | Lim WS, Baudouin SV, George RC, et al. Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; Vol. 64 (Suppl 3) | spa |
| dc.relation.references | Jasovich A, Soutric J, Morera G, Mastruzzo M, Vesco E, Izaguirre M, et al. Efficacy of amoxicillin-sulbactam, given twice-a-day, for the treatment of communityacquired pneumonia. A clinical trial based on a pharmacodynamic model. J Chemother 2002; 14: 591-6. | spa |
| dc.relation.references | Aubier M, Verster R, Regamey C, Geslin P, Vercken J B. Once-daily sparfl oxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Clin Infect Dis 1998; 26:1312-20. | spa |
| dc.relation.references | O’Doherty B, Dutchman D A, Pettit R,Maroli A. Randomized, double-blind,comparative study of grepafl oxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. J Antimicrob Chemother 1997; 40 (Suppl A): 73-81. | spa |
| dc.relation.references | Tremolieres F, de Kock F, Pluck N, Daniel R. Trovafl oxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia. Eur J Clin Microbiol Infect Dis 1998; 17: 447-53. | spa |
| dc.relation.references | Gleason PP, Kapoor WN, Stone RA, et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA 1997; 278:32–9. | spa |
| dc.relation.references | Ailani RK, Agastya G, Mukunda BN, et al. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia. Arch Intern Med.1999; 159:266–70. | spa |
| dc.relation.references | Teh B, Grayson ML, Johnson PD, Charles PG. Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Clin Microbiol Infect 2012. | spa |
| dc.relation.references | Choudhury G, Mandal P, Singanayagam A, et al. Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia- a propensity-adjusted analysis. Clin Microbiol Infect. 2011; 17:1852–8. | spa |
| dc.relation.references | Avdic E, Cushinotto LA, Hughes AH, et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis. 2012; 54(11):1581–7. | spa |
| dc.relation.references | Aliberti S, Blasi F, Zanaboni AM, et al. Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia. Eur Respir J. 2010; 36:128–34. | spa |
| dc.relation.references | Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA. 1998; 279:1452–7. | spa |
| dc.relation.references | Carratala J, Garcia-Vidal C, Ortega L, et al. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia. Arch Intern Med. 2012; 172(12):922–8. | spa |
| dc.relation.references | Menendez T, Torres A, Rodriguez de Castro F, et al. Reaching stability in community- acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis. 2004; 39:1783–90. | spa |
| dc.relation.references | Dimopoulos G, Matthaiou DK, Karageorgopoulos DE, et al. Short versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis. Drugs. 2008; 68(13):1841–54. | spa |
| dc.relation.references | Shefet D, Robenshtok E, Paul M, Leibovici L. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 2005; 165:1992–2000. | spa |
| dc.relation.references | Mills GD, Oehley MR, Arrol B. Effectiveness of b-lactam antibiotics compared with antibiotics active against atypical pathogens in nonsevere community acquired pneumonia: meta-analysis. BMJ 2005; 330:456–60. | spa |
| dc.relation.references | El Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am J Respir. Crit. Care Med 2001; 163: 645–51. | spa |
| dc.relation.references | Luna CM, Famiglietti A, Absi R, et al. Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest 2000; 118:1344–54. | spa |
| dc.relation.references | Leroy O, Santre C, Beuscart C, et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995; 21:24–31. | spa |
| dc.relation.references | Sapira JD. The Art and Science of Bedside Diagnosis. Baltimore, MD: Williams & Wilkins; 1990. 13. Forgacs P. Lung sounds. Br J Dis Chest. 1969; 63(1):1-12. | spa |
| dc.relation.references | Marrie T, Lau C, Wheeler S, Wong C J,Feagan B G. Predictors of symptom resolution in patients with community-acquired pneumonia. Clin Infect Dis 2000; 31: 1362-7. | spa |
| dc.relation.references | Metlay J P, Atlas S J, Borowsky L H,Singer D E. Time course of symptom resolution in patients with community-acquired pneumonia. Respir Med 1998; 92: 1137-42. | spa |
| dc.relation.references | Okimoto N, Yamato K, Kurihara T. Clinical predictors for the detection of community-acquired pneumonia in adults as a guide to ordering chest radiographs. Respirology.2006- 11, 322–324. | spa |
| dc.relation.references | Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clinical Infectious Diseases 2000; 31:383-421. | spa |
| dc.relation.references | Levy ML, Le Jeune I, Woodhead MA, Macfarlaned JT, Lim WS; British Thoracic Society Community Acquired Pneumonia in Adults Guideline Group. Thorax October 2009. Vol 64 Supplement III. | spa |
| dc.relation.references | Woodhead M, Blasi F, Ewig S, Huchon G,Ieven M, Ortqvist A, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-80. | spa |
| dc.relation.references | Majumdar SR, Eurich DT, Gamble JM, et al. Oxygen saturations less than 92 % are associated with major adverse events in outpatients with pneumonia: a population-based cohort study. Clin Infect Dis 2011; 52:325-31. | spa |
| dc.relation.references | Liapikou A, Ferrer M, Polverino E, Balasso V, Esperatti M, Piñer R, et al. Severe Community-acquired pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission. Clin Infect Dis 2009; 48: 377-85. | spa |
| dc.relation.references | Neill A M, Martín J R, Weir R, Anderson R,Cherevshsky A, Epton M J, et al. Communityacquired pneumonia: aetiology and usefulnesof severity criteria on admission. Thorax 1996; 51: 1010-6. | spa |
| dc.relation.references | Fine M J, Auble T E, Yealy D M, Hanusa B H, Wiessfeld L A, Singer D E, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50. | spa |
| dc.relation.references | Fine M J, Hough L J, Medsger A R, Li Y H, Ricci E M, Singer D E, et al. The hospital admission decision for patients with community-acquired pneumonia: results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 1997; 157:36-44. | spa |
| dc.relation.references | Garcia-Vazquez E, Marcos MA, Mensa J, et al. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med 2004; 164:1807–11. | spa |
| dc.relation.references | Campbell SG, Marrie TJ, Anstey R, Dickinson G, Ackroyd-Stolarz S. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 2003; 123:1142. | spa |
| dc.relation.references | Waterer GW, Wunderink RG. The influence of the severity of community- acquired pneumonia on the usefulness of blood cultures. Respir Med 2001; 95:78–82. | spa |
| dc.relation.references | Low DE, Green K, et al. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005; 40:1288-97. | spa |
| dc.relation.references | Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2000; 162:154–60. | spa |
| dc.relation.references | Van der Eerden MM, Vlaspolder F, de Graaff CS, et al. Comparison between pathogen directed antibiotic treatment and empirical broads spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomized study. Thorax 2005; 60:672–8. | spa |
| dc.relation.references | British Thoracic Society. Guidelines for the management of community acquired pneumonia in adults. Thorax 2001; 56 (Suppl 4:IV):1-64. | spa |
| dc.relation.references | Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA,Campbell GD. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. American Journal of Respiratory and Critical Care Medicine 2001; 163:1730-54. | spa |
| dc.relation.references | Hedlund J, Stralin K, Ortqvist A, Holmberg H. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scandinavian Journal of Infectious Diseases 2005; 37:791-805. | spa |
| dc.relation.references | Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, et al.Guidelines for the management of adult lower respiratory tract infections.European Respiratory Journal 2005;26:1138-80. | spa |
| dc.relation.references | Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA. 1998; 279:1452–7. | spa |
| dc.relation.references | Avdic E, Cushinotto LA, Hughes AH, et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis. 2012; 54(11):1581–7. | spa |
| dc.relation.references | Ramírez JA.Worldwide perspective of the quality of care provided to hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study. Semin Respir Crit Care Med. 2005; 26(6):543–52. | spa |
| dc.relation.references | Roson B, Carratala J, Fernandez-Sabe N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med 2004; 164:502–8. | spa |
| dc.relation.references | Tydeman DE. An investigation into the effectiveness of physiotherapy in the treatment of patients with community acquired pneumonia. Physio Pract 1989; 5:75–8. | spa |
| dc.relation.references | Chalmers JD, Taylor JK, Mandal P, et al. Validation of the Infectious Disease Society of America/America Thoracic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 2011; 53:503-11. | spa |
| dc.rights | José Gabriel Bustillo Pereira - 2018 | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.coar | http://purl.org/coar/access_right/c_abf2 | spa |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | spa |
| dc.source | https://revistas.juanncorpas.edu.co/index.php/cartacomunitaria/article/view/312 | spa |
| dc.subject | Neumonía | spa |
| dc.subject | Salud | spa |
| dc.subject | Registros médicos | spa |
| dc.subject | Manejo de caso | spa |
| dc.subject | Atención al paciente | spa |
| dc.subject | Pacientes | spa |
| dc.subject | Evaluación del resultado de la atención al paciente | spa |
| dc.title | Diez respuestas puntuales sobre neumonía adquirida en la comunidad en adultos | spa |
| dc.title.translated | Diez respuestas puntuales sobre neumonía adquirida en la comunidad en adultos | eng |
| dc.type | Artículo de revista | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
| dc.type.coarversion | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
| dc.type.content | Text | spa |
| dc.type.driver | info:eu-repo/semantics/article | spa |
| dc.type.local | Journal article | eng |
| dc.type.redcol | http://purl.org/redcol/resource_type/ARTREF | spa |
| dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
| dspace.entity.type | Publication | spa |